Lv1
80 积分 2025-07-08 加入
Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?
13小时前
已完结
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
19天前
已完结
2型糖尿病心血管结局试验的设计与思考
20天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
1个月前
已完结
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
1个月前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
1个月前
已完结
Uncertainty identification by the maximum likelihood method
1个月前
已完结
Association Between Changes in Body Composition and Physical Function After Intensive Behavioral Weight-loss Intervention: A Look AHEAD Trial Subgroup Analysis
1个月前
已关闭
Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial
1个月前
已完结
皖公网安备34019202002308
